JPWO2020189000A1 - - Google Patents

Info

Publication number
JPWO2020189000A1
JPWO2020189000A1 JP2021506204A JP2021506204A JPWO2020189000A1 JP WO2020189000 A1 JPWO2020189000 A1 JP WO2020189000A1 JP 2021506204 A JP2021506204 A JP 2021506204A JP 2021506204 A JP2021506204 A JP 2021506204A JP WO2020189000 A1 JPWO2020189000 A1 JP WO2020189000A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021506204A
Other versions
JP7414240B2 (ja
JPWO2020189000A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020189000A1 publication Critical patent/JPWO2020189000A1/ja
Publication of JPWO2020189000A5 publication Critical patent/JPWO2020189000A5/ja
Priority to JP2023214574A priority Critical patent/JP2024037980A/ja
Application granted granted Critical
Publication of JP7414240B2 publication Critical patent/JP7414240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021506204A 2019-03-20 2020-01-23 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物 Active JP7414240B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023214574A JP2024037980A (ja) 2019-03-20 2023-12-20 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019052195 2019-03-20
JP2019052195 2019-03-20
PCT/JP2020/002292 WO2020189000A1 (ja) 2019-03-20 2020-01-23 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023214574A Division JP2024037980A (ja) 2019-03-20 2023-12-20 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物

Publications (3)

Publication Number Publication Date
JPWO2020189000A1 true JPWO2020189000A1 (ja) 2020-09-24
JPWO2020189000A5 JPWO2020189000A5 (ja) 2022-12-20
JP7414240B2 JP7414240B2 (ja) 2024-01-16

Family

ID=72519262

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506204A Active JP7414240B2 (ja) 2019-03-20 2020-01-23 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物
JP2023214574A Pending JP2024037980A (ja) 2019-03-20 2023-12-20 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023214574A Pending JP2024037980A (ja) 2019-03-20 2023-12-20 Ｄ－アロースの癌細胞に取り込まれる性質を利用する薬物輸送担体、薬物輸送方法および腎細胞癌治療のための組成物

Country Status (5)

Country Link
US (1) US20220152068A1 (ja)
EP (1) EP3943078A4 (ja)
JP (2) JP7414240B2 (ja)
CN (1) CN113613639A (ja)
WO (1) WO2020189000A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021193659A1 (ja) * 2020-03-23 2021-09-30 国立大学法人 香川大学 Ｄ－アロースを有効成分として含む、腎細胞癌を治療又は予防するための組成物、及びそれを用いた癌を治療又は予防する方法
US20240002828A1 (en) 2020-11-30 2024-01-04 National University Corporation Kagawa University Novel l-rhamnose isomerase
WO2023136329A1 (ja) * 2022-01-14 2023-07-20 国立大学法人 香川大学 細胞増殖遅延剤、それを含む化粧品、及び細胞増殖を遅延させる方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097820A1 (fr) * 2002-05-22 2003-11-27 Fushimi Pharmaceutical Co.,Ltd. Procede pour utiliser l'activite physiologique d'un saccharide rare et compositions contenant un saccharide rare
WO2016152293A1 (ja) * 2015-03-20 2016-09-29 国立大学法人香川大学 癌細胞のｇｌｕｔ１の発現抑制用組成物および発現抑制方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330976B1 (ja) 1971-07-22 1978-08-30
JP3975274B2 (ja) 2003-03-31 2007-09-12 国立大学法人 香川大学 Ｄ−アロースの結晶化法による分別法とその大量生産への応用
JP2015155392A (ja) 2014-02-20 2015-08-27 弘幸 中西 グルコースと炭酸アパタイトを使用した抗癌剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097820A1 (fr) * 2002-05-22 2003-11-27 Fushimi Pharmaceutical Co.,Ltd. Procede pour utiliser l'activite physiologique d'un saccharide rare et compositions contenant un saccharide rare
WO2016152293A1 (ja) * 2015-03-20 2016-09-29 国立大学法人香川大学 癌細胞のｇｌｕｔ１の発現抑制用組成物および発現抑制方法

Also Published As

Publication number Publication date
EP3943078A1 (en) 2022-01-26
WO2020189000A1 (ja) 2020-09-24
US20220152068A1 (en) 2022-05-19
EP3943078A4 (en) 2023-01-18
JP2024037980A (ja) 2024-03-19
JP7414240B2 (ja) 2024-01-16
CN113613639A (zh) 2021-11-05

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021018450A2 (ja)
BR112021017939A2 (ja)
BR112019016141A2 (ja)
BR112021017782A2 (ja)
BR112021008711A2 (ja)
BR112019016142A2 (ja)
BR112019016138A2 (ja)
BR112021018168A2 (ja)
BR112021018452A2 (ja)
BR112021017355A2 (ja)
BR112021018102A2 (ja)
BR112021018584A2 (ja)
JPWO2020189000A1 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018093A2 (ja)
BR112021018084A2 (ja)
BR112021018484A2 (ja)
BR112021017949A2 (ja)
BR112021017983A2 (ja)
AT524962A5 (ja)
BR112019016136A2 (ja)
BR112021019344A2 (ja)
BR102019023359A2 (ja)

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20210716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230905

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20230929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231027

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231121

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20231201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20231201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231220

R150 Certificate of patent or registration of utility model

Ref document number: 7414240

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04